Analyst consensus rating
HUTCHMED (China) Analyst Rating: Buy
HCM is rated Buy by 14 analysts with a $20.99 target. As of 2026-08-29.
Direct answer
HUTCHMED (China)'s consensus rating is Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $20.99.
Forecast evidence checked August 29, 2026.
Get free HUTCHMED (China) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.38
- Average price target
- $20.99
- High price target
- $40.40
- Low price target
- $11.10
- Low target gap
- -10.3%
- Target upside
- +69.6%
- High target gap
- +226.3%
- Target range width
- 236.7%
- Consensus rating
- Buy
- Analysts
- 14
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HUTCHMED (China)?
HUTCHMED (China) has a verified Buy consensus. The same dataset has an average price target of $20.99.
How far are HUTCHMED (China)'s low and high targets from the recorded price?
The low target implies -10.3%, while the high target implies +226.3%.
How many analysts are included in HUTCHMED (China)'s consensus?
The verified consensus includes 14 analysts.
How is HUTCHMED (China)'s target upside or downside calculated?
The average target of $20.99 is divided by the recorded price of $12.38, then one is subtracted to produce +69.6%. This does not guarantee a future return.
When was HUTCHMED (China)'s analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.